Anirban Maitra
Anirban Maitra/LinkedIn

Anirban Maitra: New Study on TET2-Mutant Clonal Hematopoiesis and Immunotherapy Response

Anirban Maitra, Scientific Director of Sheikh Ahmed Center for Pancreatic Cancer Research and Professor of Pathology and Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center, shared a post on X about a paper by Shelley Herbrich et al. published in Cancer Cell:

“An intriguing study from Shelley Herbrich and Pam Sharma MD Anderson Cancer Center published in Cancer Cell.
TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors

Making lemonade out of CH lemons!

Title: TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors

Authors: Shelley Herbrich, Mehdi Chaib, Swetha Anandhan, Samuel W. Andrewes, Ashwat Nagarajan, Baoxiang Guan, Nishant Gandhi, Jared Gilliam, Milan Radovich, Padmanee Sharma

You can read the Full Article in Cancer Cell.

Anirban Maitra: New Study on TET2-Mutant Clonal Hematopoiesis and Immunotherapy Response

More posts featuring Anirban Maitra.